Naratuximab emtansine Uses, Dosage, Side Effects and more
Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).
| Trade Name | Naratuximab emtansine |
| Generic | Naratuximab emtansine |
| Naratuximab emtansine Other Names | Naratuximab emtansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
